Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA
|
BSE: 524715
|
ISIN: INE044A01036
|
Industry: Pharmaceuticals
|
Mid-range Performer
1664.8000
-10.90
(
-0.65
%)
NSE
Jul 01, 2025
13:53 PM
Volume:
2.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Sun Pharmaceutical Industries Ltd.
08 Dec 2022
1664.80
-0.65%
Sun Pharma's Halol plant gets USFDA import alert
Business Line
Sun Pharma is second Indian drugmaker to get import alert in less than two months
Sun Pharmaceutical Industries Ltd. is trading below all available SMAs
Sun Pharma's Halol facility listed under USFDA import alert
Moneycontrol |
08 Dec 2022
4 more
Sun Pharma plant in Gujarat listed under US FDA import alert, says company
Business Standard |
08 Dec 2022
Sun Pharma says plant listed under U.S. FDA import alert
Business Line |
08 Dec 2022
Sun Pharma slips nearly 4% as USFDA issues import alert on Halol facility
Business Standard |
08 Dec 2022
USFDA lists Sun Pharma's Halol facility under 'import alert'
Moneycontrol |
08 Dec 2022
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market trades flat, Apollo Hospitals plans to spin off its pharmacy and digital health business
Trendlyne Marketwatch |
01 Jul 2025, 01:44PM
IPOs This Week: Fifteen Upcoming Listings; Crizac Plus Eight New Issues
|
30 Jun 2025, 04:24PM
Change is hard, and some Indian pharma companies are embracing it better than others
|
09 Aug 2022